The World Health Organization has classified antibiotic resistance as one of the greatest threats to global health, projecting it could kill as many as 208 million people in 25 years.
Phage therapy, which uses bacteriophage viruses to target antibiotic-resistant bacteria, has shown therapeutic potential, yet its resurgence in the West has been stifled by regulatory and knowledge gaps.
The scientific community is now betting on phage therapy as a viable solution against superbugs, supported by new funding to augment research into phages.
Historically sidelined by the discovery of penicillin, phage therapy is experiencing a renaissance as antibiotic resistance reaches critical levels, with growing interest and renewed scientific inquiry.
Collection
[
|
...
]